Clemastine for Depression in Older Adults
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests if adding clemastine (an allergy medication) to standard antidepressants can improve brain health and boost treatment response in adults over 60 with depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You have been diagnosed with major depression
- You are currently seeking treatment for depression
- You score at least 15 on a standard depression scale (MADRS)
- You score above 24 on a cognitive screening test (MoCA)
- You are fluent in English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a sleep treatment to regular depression medication can improve both mood and sleep in adults aged 55 and older. It may help if you have ongoing depression, sleep problems, and are already taking antidepressant medication.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
This trial studies how depression and antidepressants affect belief updating in older adults. You may join if you are over 65, have major depression, and are starting a new antidepressant. The goal is to learn more about how your brain adjusts beliefs over time.
This study tests whether a combination of an antihistamine called clemastine plus aerobic exercise can help improve thinking and memory problems in people with schizophrenia. It aims to see if this approach can repair nerve insulation in the brain, potentially restoring cognitive function.
This study looks at how a brain protein linked to Alzheimer’s disease changes over time in older adults who have major depression but no major memory problems. It involves brain scans, blood and urine tests, and a spinal fluid sample to better understand the connection between depression and brain aging.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.